Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Aug 03, 2022 6:30am EDT

Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange

Apr 26, 2022 8:00am EDT

Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board

Mar 31, 2022 8:30am EDT

Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board

Mar 22, 2022 8:00am EDT

Sigyn Therapeutics Announces Filing of 2021 Annual Report on Form 10-K

Mar 15, 2022 9:00am EDT

Sigyn Therapeutics™ Appoints H. David Humes, MD to Its Scientific Advisory Board

Mar 09, 2022 9:00am EST

Sigyn Therapeutics Appoints Alexander S. Yevzlin, MD, FASN to Its Scientific Advisory Board

Mar 02, 2022 8:00am EST

Sigyn Therapeutics™ Appoints Accomplished Financial Executive, Jeremy Ferrell, as Chief Financial Officer

Feb 23, 2022 8:00am EST

Sigyn Therapeutics™ Announces Completion of Animal Studies

Jan 04, 2022 7:30am EST

Sigyn Therapeutics CEO Note: 2021 Milestone Achievements / 2022 Clinical Progression / Images of Sigyn Therapy in Action

Dec 17, 2021 8:30am EST

Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or Vaccines

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap